C01CA04 - Dopamine |
Not porphyrinogenic |
NP |
Rationale
Endogenous substance. Non-CYP metabolism. No data pointing to CYP-interaction.
Therapeutic characteristics
Endogenous signal substance liberating noradrenaline. Used in shock due to its inotropic effect on heart minute volume.
Metabolism and pharmacokinetics
Metabolized by monoamine oxidase and COMT, primarily in the liver.
Personal communication
Stig Thunnel 2004: Used in Swedish porphyria ward.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Scientific articles | |
| 1. | Guideline for application of anesthesia in patients with porphyria. [German]. Anasthesiologie und Intensivmedizin 2002; 43(7-8):485-488.
Bohrer H, Olthoff D, Roewer N, Schulte am Esch HCJ. |
|
Tradenames
Dopaminehydrochloride · Neoatricon 
Neoatricon 
Dopamina · Neoatricon 
Dopamin · Neoatricon 
Clorhidrat Dopamina 
Dopamin 
Dopamine · Dopamine hydrochloride 
Dopmin · Neoatricon 
Dopamin 
Dopaminum · Neoatricon 
Dopamine 
Dopamin 
Neoatricon 
Dopmin · Neoatricon 
Dopamine · Neoatricon 
Neoatricon 
Dopmin · Neoatricon 
Dopamin 
Neoatricon 
Dopamina 
Dopamine